Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

JOURNAL OF HISTOTECHNOLOGY, published by Taylor & Francis Ltd, is a leading academic journal dedicated to advancing the field of histotechnology, which plays a crucial role in both clinical and research settings. With an established history since 1977, this journal serves as a critical platform for researchers, professionals, and students engaged in the intricate study of tissue processing, staining techniques, and microscopic analysis. It is currently indexed in reputable databases, reflecting its commitment to scientific rigor, with a notable presence in categories such as Anatomy, Histology, and Medical Laboratory Technology. Despite its open access status being limited, the Journal of Histotechnology maintains a respectable impact factor and ranks within the third quartile for Anatomy and Medical Laboratory Technology, and fourth quartile for Histology in 2023, emphasizing its relevance in the scholarly community. As the field continues to evolve, this journal aims to foster innovation and dissemination of knowledge within histotechnology, making it an essential resource for those looking to further their expertise and contribute to the advancements in this vital area of health sciences.

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.

Cells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.

The International Journal of Developmental Biology, published by the University of Basque Country UPV-EHU Press, has been a pivotal resource in the field of developmental biology since its inception in 1989. With an ISSN of 0214-6282 and an E-ISSN of 1696-3547, this journal serves as a platform for groundbreaking research and exploration within the realms of embryology and developmental biology. Although currently classified in the Q4 category for Developmental Biology and Q3 in Embryology as of 2023, the journal continues to provide vital insights that influence contemporary scientific understanding and practices. It ranks 14th out of 21 in the field of Embryology and holds a 35th percentile ranking in this specialized domain, emphasizing its emerging relevance in the academic community. Researchers, professionals, and students alike are encouraged to utilize the journal’s content to enrich their knowledge and drive innovation within developmental sciences. With an eye towards future developments, the journal anticipates continued evolution through the years, maintaining its commitment to high-quality, impactful research.

Journal of Developmental Biology, published by MDPI, is an esteemed open access journal that has been contributing to the field since its inception in 2013. With a focus on developmental processes across various biological systems, this journal serves as a vital platform for disseminating cutting-edge research and fostering dialogue among experts in the fields of Cell Biology, Developmental Biology, and Molecular Biology. The journal currently holds a commendable Q2 ranking in both Developmental Biology and Molecular Biology, underscoring its significance in advancing knowledge within these domains. Operating out of Switzerland, and featuring an engaging array of articles, the journal prioritizes accessibility through its Open Access model, further expanding the reach of vital research findings. Whether you are a seasoned researcher or an enthusiastic student, the Journal of Developmental Biology provides an essential resource for the latest insights and developments in this rapidly evolving field.

Anatomy & Cell Biology is a prominent academic journal published by MEDRANG, dedicated to advancing the fields of anatomy and cell biology through the dissemination of high-quality research. With an ISSN of 2093-3665 and an E-ISSN of 2093-3673, this journal serves as a vital resource for researchers and professionals interested in understanding the intricate processes of human and model organism anatomy and cellular functions. Based in South Korea, Anatomy & Cell Biology has gained recognition with a 2023 Category Quartile ranking of Q2 in Anatomy and continues to foster academic collaboration and innovation since its inception in 2014. With a focus on interdisciplinary studies, the journal publishes essential findings that contribute to the realms of histology, developmental biology, and neuroscience. Although the journal operates on a subscription model, it remains committed to providing valuable insights and a platform for scholarly dialogue among those in the biological sciences. Researchers and students aiming to remain at the forefront of these dynamic fields will find Anatomy & Cell Biology an indispensable part of their academic journey.

European Journal of Translational Myology is a premier, open access journal published by PAGEPRESS PUBL, dedicated to advancing research in the dynamic field of myology and its applications in various medical disciplines. Established in 2010, this journal disseminates crucial findings pertinent to translational myology, covering aspects within Cell Biology, Molecular Biology, Neurology, and Orthopedics and Sports Medicine. With a notable presence in the Scopus rankings and respectable quartiles across various categories, including Q3 positions in key areas as of 2023, the journal offers an invaluable platform for researchers and clinicians aiming to bridge the gap between experimental research and clinical practice. Located in Pavia, Italy, the journal welcomes contributions from scholars worldwide, fostering a collaborative environment that enhances knowledge exchange and encourages innovative approaches in myological research.

CONGENITAL ANOMALIES is a notable journal published by WILEY, dedicated to advancing the understanding of congenital disorders and anomalies through high-quality research and clinical insights. With an ISSN of 0914-3505 and an E-ISSN of 1741-4520, this journal has been a key resource for professionals in the fields of pediatrics, embryology, and developmental biology since its inception in 1973, although coverage discontinued in Scopus after 2019 due to evolving standards in publication. The journal is ranked in the 48th percentile in the domain of pediatrics, as well as in the 26th and 14th percentiles respectively for embryology and developmental biology, placing it among respected publications in its category. Although it does not currently offer open access options, its contributions remain vital for researchers, healthcare professionals, and students seeking up-to-date information on congenital anomalies, their origins, and potential interventions. With a commitment to fostering knowledge in this critical area of health science, CONGENITAL ANOMALIES continues to play an important role in the intersection of scientific research and clinical practice.

JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.